TBPH
Theravance Biopharma Inc
17.00$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.9 | 0.9 | 0.8 | 0.7 | – | – | – | – | – | – | – | 42.8 | 25.8 | 9.4 | 7.3 | 16.3 | |
| 35.9 | 32.5 | 57.0 | 66.3 | 108.6 | 95.9 | 62.8 | 30.1 | 36.1 | 23.1 | 21.7 | 15.1 | 18.3 | 19.8 | 15.6 | 17.2 | 11.3 | 15.8 | 19.9 | 14.8 | 9.2 | 14.8 | 13.3 | 13.2 | 14.8 | 14.7 | 14.1 | 11.5 | 8.3 | 9.6 | 7.1 | 6.7 | 6.3 | 7.2 | 6.8 | 7.2 | 9.4 | 9.2 | 7.6 | 8.4 | |
| 5.6 | 4.5 | 6.5 | 8.6 | 9.8 | 12.8 | 20.4 | 35.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.6 | 1.7 | 1.9 | 2.1 | 1.8 | 2.6 | 2.1 | 2.1 | 2.1 | 2.6 | 2.7 | 2.5 | 3.3 | 3.3 | 2.9 | 3.0 | |
| 38.8 | 34.6 | 65.3 | 76.1 | 130.1 | 119.2 | 78.4 | 38.6 | 38.6 | 24.4 | 25.8 | 19.8 | 24.3 | 25.3 | 14.5 | 18.9 | 13.1 | 18.2 | 21.8 | 15.3 | 17.6 | 24.4 | 16.0 | 23.6 | 6.7 | 9.0 | 10.4 | 9.6 | 7.1 | 9.0 | 6.3 | 6.0 | 6.0 | 6.8 | 5.2 | 3.7 | 7.4 | 7.8 | 5.0 | 6.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.4 | 11.4 | 6.2 | 3.9 | 9.7 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 13.7 | 2.3 | 3.1 | 4.2 | 3.1 | 17.0 | |
| -6.4% | -6.4% | -6.6% | -6.6% | -10.4% | -13.8% | -8.2% | -10.1% | -6.3% | -8.6% | -20.0% | -26.0% | -21.1% | -16.6% | -15.7% | -16.8% | -27.4% | -22.7% | -20.7% | -28.1% | -43.1% | -25.7% | -23.0% | -18.8% | -13.9% | -24.8% | -25.3% | -29.2% | -33.8% | -5.3% | -4.2% | -2.3% | -3.1% | -2.6% | 7.3% | 43.9% | 32.1% | 24.0% | 32.4% | 5.9% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 89.4% | 94.1% | 92.0% | 89.1% | 75.5% | 60.8% | 69.5% | -28.4% | -5.4% | 18.3% | -78.3% | -69.1% | -156.2% | -107.3% | -11.9% | 32.3% | 100.0% | 9.3% | -100.4% | -186.6% | -285.1% | -250.1% | -175.2% | -116.0% | -53.5% | -23.5% | -12.7% | 4.0% | 25.4% | 41.4% | 54.4% | 53.9% | 42.2% | 41.5% | 38.5% | 47.3% | 50.8% | 70.6% | 81.7% | 89.4% | |
| -380.8% | -371.0% | -593.1% | -686.4% | -1,441.7% | -1,690.6% | -1,291.4% | -615.6% | -519.5% | -395.5% | -431.2% | -401.6% | -409.0% | -343.1% | -285.1% | -365.2% | -353.2% | -414.4% | -466.7% | -469.3% | -470.6% | -466.1% | -389.2% | -324.7% | -253.1% | -179.1% | -164.0% | -141.7% | -123.3% | -97.6% | -68.8% | -67.6% | -69.6% | -72.9% | -76.9% | -48.2% | -40.9% | -5.6% | 2.3% | 4.5% | |
| -358.9% | -391.9% | -641.7% | -742.6% | -1,604.9% | -1,855.0% | -1,383.1% | -639.9% | -513.3% | -357.0% | -388.6% | -369.7% | -370.5% | -322.1% | -280.8% | -351.6% | -345.2% | -386.9% | -414.5% | -411.7% | -382.1% | -360.6% | -268.6% | -193.7% | 1,646.8% | 1,698.5% | 1,803.7% | 1,694.2% | -104.7% | -96.1% | -72.8% | -73.6% | -78.2% | -87.6% | -89.4% | 16.9% | 36.5% | 98.5% | 104.3% | 51.6% | |
| -228.3% | -207.9% | -374.3% | -437.6% | -1,132.1% | -1,322.4% | -513.1% | -303.5% | -225.6% | -199.0% | -434.9% | -392.2% | -384.6% | -328.8% | -244.5% | -289.2% | -310.4% | -357.7% | -411.5% | -416.4% | -396.9% | -382.0% | -305.9% | -249.2% | -205.5% | -365.3% | -357.0% | -335.2% | -279.4% | -51.3% | -30.0% | -15.5% | -19.5% | -18.4% | 49.5% | 317.0% | 303.1% | 221.9% | 244.8% | 49.7% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -56.5% | -54.4% | -72.7% | -96.6% | -144.4% | -247.8% | -449.8% | -755.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 177.0% | 197.4% | 236.4% | 310.0% | -23.2% | -25.9% | -21.9% | -23.6% | -26.6% | -32.1% | -35.1% | 5.8% | 12.6% | 35.7% | 39.4% | 18.6% | |
| -47.2% | -29.8% | -36.4% | -42.8% | -54.7% | -64.7% | -59.4% | -61.6% | -68.0% | -38.5% | -42.0% | -45.1% | -49.6% | -57.8% | -40.8% | -47.8% | -55.7% | -59.3% | -73.2% | -61.5% | -56.0% | -53.2% | -41.0% | -28.1% | 111.4% | 143.6% | 162.7% | 194.5% | -13.8% | -14.4% | -12.1% | -12.6% | -13.9% | -15.9% | -17.0% | 3.1% | 7.1% | 21.8% | 24.3% | 11.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 136 | 101 | 276 | 307 | 356 | 359 | 322 | 345 | 123 | 76 | 232 | 285 | 361 | 405 | -99 | 130 | 143 | 175 | 126 | 31 | 495 | 527 | 147 | 540 | -418 | -291 | -180 | -96 | -62 | -36 | -50 | -42 | -19 | -27 | -100 | -271 | -164 | -157 | -277 | -209 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -6.1 | -3.2 | -1.2 | -2.0 | -3.0 | |
| 83.6% | 54.8% | 50.0% | 44.3% | 37.9% | 26.1% | 13.2% | 8.2% | -3.6% | -9.2% | -21.3% | -27.9% | -41.0% | -54.8% | -26.1% | -35.9% | -51.1% | -64.8% | -99.5% | -70.0% | -80.3% | -90.3% | -98.9% | -97.0% | 62.9% | 72.7% | 68.8% | 62.7% | 59.5% | 55.8% | 55.2% | 53.5% | 52.1% | 49.6% | 48.3% | 52.8% | 56.0% | 61.1% | 61.5% | 61.7% | |
| 0.7 | 1.3 | 1.5 | 1.9 | 2.4 | 3.9 | 7.1 | 13.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -3.62 | -3.85 | -4.14 | -4.46 | -5.05 | -5.39 | -5.35 | -4.83 | -4.65 | -3.95 | -4.06 | -4.00 | -3.96 | -4.21 | -4.15 | -4.29 | -4.51 | -4.36 | -4.26 | -4.02 | -3.07 | -2.70 | -1.94 | -1.33 | 11.26 | 12.94 | 13.92 | 15.32 | -1.09 | -1.12 | -0.93 | -0.94 | -1.01 | -1.14 | -1.17 | 0.26 | 0.57 | 2.00 | 2.23 | 1.04 | |
| 1.01 | 0.98 | 0.65 | 0.60 | 0.31 | 0.29 | 0.39 | 0.75 | 0.91 | 1.11 | 1.04 | 1.08 | 1.07 | 1.31 | 1.48 | 1.22 | 1.31 | 1.13 | 1.03 | 0.98 | 0.80 | 0.75 | 0.72 | 0.69 | 0.68 | 0.76 | 0.77 | 0.90 | 1.04 | 1.16 | 1.27 | 1.27 | 1.29 | 1.31 | 1.31 | 1.52 | 1.55 | 2.03 | 2.14 | 2.02 | |
| 6.41 | 7.07 | 5.69 | 4.61 | 3.50 | 2.18 | 1.19 | 0.64 | -0.25 | -0.95 | -2.06 | -2.47 | -3.27 | -3.99 | -2.66 | -3.22 | -4.13 | -4.77 | -5.79 | -4.57 | -4.40 | -4.58 | -4.67 | -4.59 | 6.36 | 6.56 | 5.89 | 4.94 | 4.70 | 4.31 | 4.24 | 3.97 | 3.79 | 3.56 | 3.34 | 4.43 | 4.48 | 5.59 | 5.67 | 5.61 | |
| -2.30 | -2.04 | -2.42 | -2.63 | -3.56 | -3.85 | -1.99 | -2.29 | -2.04 | -2.20 | -4.54 | -4.24 | -4.11 | -4.30 | -3.62 | -3.53 | -4.05 | -4.03 | -4.23 | -4.07 | -3.19 | -2.86 | -2.21 | -1.71 | -1.41 | -2.78 | -2.76 | -3.03 | -2.91 | -0.60 | -0.38 | -0.20 | -0.25 | -0.24 | 0.65 | 4.83 | 4.69 | 4.50 | 5.24 | 1.00 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.